Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Study ID: NCT05663710
Start Date: 2023-06-30
End Date: 2027-10-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

177 Lu GirantuSimab

Nivolumab

Cabozantinib

ArabinoFuranosylGuanine [18F]F-AraG

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

Study ID: NCT06036810
Start Date: 2023-08-31
End Date: 2027-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Shared Medical Decision Tool

Engaging Patients in Decision Making

Literacy Spanish Language

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Study ID: NCT05671510
Start Date: 2023-06-28
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

600

Intervention / Treatment

Gotistobart

Docetaxel

Sponsor

OncoC4, Inc.

Source: clinicaltrials.gov

Share:
Add to list

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

Study ID: NCT06111781
Start Date: 2024-04-15
End Date: 2028-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Relugolix 120 MG [Orgovyx]

SBRT standard of care radiotherapy treatment

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Study ID: NCT06246110
Start Date: 2024-02-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

Eik1001

Pembrolizumab

Paclitaxel

Pemetrexed

Carboplatin

Sponsor

Eikon Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Study ID: NCT06628310
Start Date: 2024-12-13
End Date: 2030-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

180

Intervention / Treatment

Abbv-400

Budhiglimab

Fluorouracil

Leucovorin

Oxaliplatin

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Study ID: NCT06116110
Start Date: 2024-05-15
End Date: 2039-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Long-term Follow-Up

Sponsor

Miltenyi Biomedicine GmbH

Source: clinicaltrials.gov

Share:
Add to list

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

Study ID: NCT06745895
Start Date: 2024-10-21
End Date: 2028-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

350

Intervention / Treatment

MATCHES

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

Study ID: NCT03699995
Start Date: 2018-05-18
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Confocal Microscopy

Dermoscopy

Imaging Procedure

Lidocaine

Punch Biopsy

Shave Biopsy

Sponsor

OHSU Knight Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

The Leukemia and Lymphoma Society (LLS) National Research Registry

Study ID: NCT04806295
Start Date: 2017-07-24
End Date: 2027-07-23
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

any/all treatments for blood cancer

Sponsor

Lymphoma and Leukemia Society

Source: clinicaltrials.gov

Share:
Add to list